Clinical trial for Attention Deficit/Hyperactivity Disorder(ADHD)
Official title Smartphone-based Intervention for Young Adults With ADHD
ClinicalTrials.gov ID: NCT07654205
What this study is testing
- What it's testing
- The study wants to find out if a smartphone program is doable and acceptable for young adults with ADHD who also drink riskily, and whether it might help with symptoms and drinking.
- Who it's for
- Young adults who have ADHD and report risky alcohol use.
- What's involved
- You will join a virtual baseline visit, then use either the study app or a control app for 31 days, and later complete a virtual follow‑up visit with similar questionnaires.
- Time commitment
- The study lasts about one month, with a virtual visit at the start, daily app use for 31 days, and a virtual follow‑up visit at the end.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 25
You may be able to join if
- Age 18-25
- Current diagnosis of Attention Deficit/Hyperactivity Disorder-Combined Type according to the Diagnostic and Statistical Manual of Mental Disorders -...
- Drinks at least 4 (for females) / 5 (for males) alcoholic drinks in a single drinking session at least once per week
- Owns a smartphone
- Reads and understands English
You likely can't join if
- Currently in high school
- Actively in treatment for Alcohol Use Disorder
The study team makes the final eligibility decision.
Where it is enrolling
- Pittsburgh, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 25 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.